UPDATE 1-CVS starts selling Impax's cheaper EpiPen rival

Jan 12 (Reuters) - Drugstore chain CVS Health Corp has started selling a generic version of Impax Laboratories Inc's emergency allergy injection, a device similar to Mylan NV's controversial EpiPen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.